CH654743A5 - Pharmaceutical composition with antiulcer, spasmolytic and local anaesthetic action - Google Patents
Pharmaceutical composition with antiulcer, spasmolytic and local anaesthetic action Download PDFInfo
- Publication number
- CH654743A5 CH654743A5 CH4782/83A CH478283A CH654743A5 CH 654743 A5 CH654743 A5 CH 654743A5 CH 4782/83 A CH4782/83 A CH 4782/83A CH 478283 A CH478283 A CH 478283A CH 654743 A5 CH654743 A5 CH 654743A5
- Authority
- CH
- Switzerland
- Prior art keywords
- spasmolytic
- pharmaceutical composition
- antiulcer
- active ingredient
- antacid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19833333008 DE3333008A1 (de) | 1983-09-13 | 1983-09-13 | Pharmazeutische mittel mit antiulceroeser, spasmolytischer und lokalanaesthetischer wirkung |
Publications (1)
Publication Number | Publication Date |
---|---|
CH654743A5 true CH654743A5 (en) | 1986-03-14 |
Family
ID=6208945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH4782/83A CH654743A5 (en) | 1983-09-13 | 1983-08-31 | Pharmaceutical composition with antiulcer, spasmolytic and local anaesthetic action |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPS6067421A (fr) |
BE (1) | BE897823A (fr) |
CH (1) | CH654743A5 (fr) |
DE (1) | DE3333008A1 (fr) |
NL (1) | NL8303098A (fr) |
SE (1) | SE462420B (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6103380A (en) | 1998-06-03 | 2000-08-15 | Cabot Corporation | Particle having an attached halide group and methods of making the same |
-
1983
- 1983-08-31 CH CH4782/83A patent/CH654743A5/de not_active IP Right Cessation
- 1983-09-07 NL NL8303098A patent/NL8303098A/nl not_active Application Discontinuation
- 1983-09-08 SE SE8304818A patent/SE462420B/sv not_active IP Right Cessation
- 1983-09-13 DE DE19833333008 patent/DE3333008A1/de active Granted
- 1983-09-19 JP JP58171407A patent/JPS6067421A/ja active Granted
- 1983-09-26 BE BE0/211577A patent/BE897823A/fr not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SE8304818L (sv) | 1985-03-09 |
JPS6067421A (ja) | 1985-04-17 |
DE3333008A1 (de) | 1985-03-21 |
SE462420B (sv) | 1990-06-25 |
NL8303098A (nl) | 1985-04-01 |
JPH045003B2 (fr) | 1992-01-30 |
SE8304818D0 (sv) | 1983-09-08 |
BE897823A (fr) | 1984-01-16 |
DE3333008C2 (fr) | 1990-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE19541128C2 (de) | Stabilisierte schilddrüsenhormonhaltige Arzneimittel | |
DE69623634T2 (de) | Pharmazeutische zusammensetzung von l-dopa ethyl ester | |
DE69218557T2 (de) | Stabile Zusammensetzung die ein Enalapril-Salz enthält, Verfahren zu ihrer Herstellung und ihre Verwendung | |
EP0193056B1 (fr) | Combinaison de la flupirtine avec des spasmolytiques à effet anticholinergique | |
DE2523998A1 (de) | Pharmazeutische zubereitung fuer die behandlung der schizophrenie | |
DE69721756T2 (de) | Paroxetine zur behandlung von depression | |
DE3604575A1 (de) | Kombination von flupirtin und anticholinergisch wirkenden spasmolytika | |
EP0476113B1 (fr) | Medicament pour le traitement de l'hyperlipemie et/ou de l'atherosclerose | |
DE69328792T2 (de) | Behandlung von migräne | |
DE3779842T2 (de) | Antiallergisches mittel. | |
CH621333A5 (fr) | ||
DE3035494A1 (de) | Carnitin enthaltendes arzneimittel zur behandlung von hyperlipidaemie und hyperlipoproteinaemie, sowie verwendung von carnitin zur herstellung eines solchen arzneimittels | |
CH654743A5 (en) | Pharmaceutical composition with antiulcer, spasmolytic and local anaesthetic action | |
DE69121058T2 (de) | Salze von Glykosaminoglykanen mit Aminosäureester, ihre Herstellung sowie sie enthaltende pharmazeutische Zusammensetzungen | |
DE2748291A1 (de) | Triglyceride, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von entzuendungen | |
CH655243A5 (de) | Arzneimittelkombination und verfahren zu ihrer herstellung. | |
DE68905424T2 (de) | Alpha-glucosidaseinhibitor zur foerderung der calciumabsorption. | |
DE3027056A1 (de) | Pharmazeutischer ansatz zur verwendung als schutz gegen akutes lungenoedem, anaphylaktischen schock u.a. arten von schock sowie hyperfibrinolyse | |
DE69426317T2 (de) | Verwendung von Beta-Naphthochinonderivaten zur Hemmung von Blutplättchen-Aggregation | |
DE2059620A1 (de) | Neuartige Aminoaethansulfonsaeurederivate | |
DE2413803A1 (de) | Pharmazeutische zusammensetzungen aus gemischten salzen von sulfoglykopeptiden mit metallbasen und organischen basen | |
DE2143203A1 (de) | Arzneimittel mit ulcusheilender wirkung | |
DE2532180C2 (de) | Verwendung von Etozolin bei der Bekämpfung der Hypertonie | |
DE2823267A1 (de) | Antihypertensive praeparate | |
EP1326588B1 (fr) | Formes de preparations orales d'extraits de boswellia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |